Refine by
Cancer Patient Software
16 software items found
by:Portable Medical Technology Ltd. based inKillarney, IRELAND
ONCOpatient is a digital solution to monitor cancer patients’ health from their homes. This empowers them to manage their condition more effectively with fewer hospital visits and, ultimately, increasing their chances of a good life quality and positive outcomes. ONCOpatient helps healthcare professionals in improving patient-provider ...
by:Molecular Health GmbH based inHeidelberg, GERMANY
Independent of the sequencing technology used, MH Guide can make complex datasets readable, and automatically identify genetic variants that are relevant for the treatment of cancer ...
by:Moovcare, By Sivan Innovation LTD based inParis, FRANCE
Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients. A Class I medical device, Moovcare has been proven in clinical trials to improve overall survival by 7.6 ...
by:Sivan Innovation LTD based inParis, FRANCE
Moovcare® is the first digital therapeutics reimbursed in France! Moovcare® defines a new reality in cancer follow-up, by empowering patients with symptoms management and providing the medical team a reliable digital tool to monitor their patients. Symptoms management is essential from a psychological and physical point of view when ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Lumin Bioinformatics is a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The power of Lumin is in the ability to explore and perform analysis on rich and unique datasets assembled from over 12,000 cancer patients, including thousands ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
The OTraces technology platform drives multiple business opportunities. The software is embedded into a laboratory information management system (LIMS) wherein all patient and instrument data is stored in secure U.S. based servers. This software is the principal value-add for the company’s instrument systems now being developed for prostate and eventually breast ...
by:Navigating Cancer, Inc. based inSeattle, WASHINGTON (USA)
Enable real-time oral adherence and symptom reporting while patients are on treatment. Receive proactive information on side effects and intervene quickly. Empower patients to stay on treatment with medication reminders and digital at-home care ...
by:Navigating Cancer, Inc. based inSeattle, WASHINGTON (USA)
Provide streamlined care coordination through standardized orders and care pathways. Stratify patients into care populations and prioritize management of high-risk patients. Automatically assign tasks to the appropriate staff member (so patients receive the right care at the right ...
by:EnClear Therapies based inNewburypor, MASSACHUSETTS (USA)
ELC1: LEPTOMENINGEAL CARCINOMATOSIS (LC). A devastating form of Cancer effecting 110,000 Patients/Yr. US, with a current life expectancy 2-7 months. Involvement by cancer of pia & arachnoid mater of the brain with the subarachnoid space in between. High incidence from breast, lung & ...
by:Inspirata, Inc based inTampa, FLORIDA (USA)
Digital pathology is more than simple image viewing and evaluation. Dynamyx™ streamlines case management by exploiting advances in image digitization and solution interoperability to ensure the accelerated return of patient ...
by:Qlucore AB based inLund, SWEDEN
Qlucore's clinical diagnostics solutions for multi-omics companion and precision diagnostics include AI-powered, disease-specific machine learning based classifier models and are combined with patient-friendly visualizations in a an easy-to-use and cost-effective software solution which integrates with a wide range of data generating techniques and instruments. ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
HALO AI is a collection of train-by-example classification and segmentation tools underpinned by advanced deep learning neural network algorithms. HALO AI classifiers can be trained to quantify tissue classes, to segment tissue classes for analysis with other HALO image analysis modules, to find rare events or cells in tissues, and to categorize cell populations into specific ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling ...
by:Immunai based inNew York, NEW YORK (USA)
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel ...